SPHK2 and non-small cell lung carcinoma: These results were similar to those reported from the study by Yang et al. (20) demonstrating that SphK2 expression correlated negatively with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sensitivity in three NSCLC cell lines.